Pfizer Inc. won U.S. approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business.
The treatment, called Beqvez, gained clearance for .
Pfizer's First Gene Therapy Gets Approval for Clotting Disorder bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
BioMarin shares long-term results for haemophilia A gene therapy Roctavian pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
By Deena Beasley (Reuters) - High cost, logistical issues and the prospect of potential treatment advances are holding back adoption of the first gene.
High cost, logistical issues and the
prospect of potential treatment advances are holding back
adoption of the first gene therapies for hemophilia, experts
said this week during the American Society.